Interestingly, however, the recent studies revealed that metformin, commonly used anti-diabetic drug, inhibits the HIF-1 stabilization/HIF-1 signaling in human hepatocellular carcinoma [11], cervical squamous carcinoma cells [12] and oral squamous cell carcinoma [13]. This evidence concerns the gene HIF1A and hepatocellular carcinoma.